Celldex Therapeutics (CLDX) Total Debt (QoQ) (2011 - 2013)

Celldex Therapeutics (CLDX) Total Debt (QoQ) (2011 - 2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Celldex Therapeutics 3.29 Bn 2.58 Bn -2.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2013 38.74%
Dec 31, 2012 -10.16%
Sep 30, 2012 -34.25%
Jun 30, 2012 26.41%
Mar 31, 2012 0.26%
Dec 31, 2011 0.25%
Sep 30, 2011 0.25%
Jun 30, 2011 0.45%
Mar 31, 2011 50.00%